News tagged with 'Amylin Pharmaceuticals'

A new class of diabetes drugs has shown promising results in a clinical trial conducted to help bring it to market. If approved, liraglutide would be the second GLP-1 diabetes medicine approved by the FDA for sale in the U.S. Byetta was the first.

Eli Lilly and Amylin Pharmaceuticals now say there have been four deaths associated with their drug for type-2 diabetes, Byetta.  Amylin shares plunged by 24 percent at midday after executives disclosed Tuesday night the additional deaths "in the interest of transparency."

People taking the type 2 diabetes drug, Byetta received an FDA warning Monday after it was reported that two people taking the drug died and four others were recovering from pancreatitis. People on the drug with any pancreas problems should stop taking it.